58,937 Pages

Icarus's Wish (28x28px)

JZL184, IUPAC name 4-nitrophenyl 4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate, was a small-molecule chemical compound that was a specific inhibitor of monoacylglycerol lipase (MAGL), with near-complete inhibition at approximately 1.0 nM.[1]

Behind the ScenesEdit

  • In the real world, JZL184 was synthesized and characterized by Long et al. in 2009 at the Scripps Research Interest at California, United States of America.
  • Article writer RelentlessRecusant found out about JZL184 through his personal studies in chemical biology.


  1. Long et. al (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produced cannabinoid behavioral effects. Nature Chemical Biology (5): 37-44.
Community content is available under CC-BY-SA unless otherwise noted.